Valby, Denmark

Daniel Sejer Pedersen

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 7.1

ph-index = 8

Forward Citations = 595(Granted Patents)


Location History:

  • Copenhagen, DK (2006)
  • Cambridge, GB (2009 - 2011)
  • Cambridge, DK (2013)
  • Adelaide, AU (2015)
  • Valby, DK (2015 - 2018)

Company Filing History:


Years Active: 2006-2018

Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: **Innovative Contributions of Daniel Sejer Pedersen in Antisense Therapy**

Introduction

Daniel Sejer Pedersen, an accomplished inventor based in Valby, Denmark, has significantly contributed to the field of pharmaceuticals with his innovative work. Holding a total of 12 patents, his research focuses on the development of novel therapies utilizing Locked Nucleic Acids (LNA). Through his inventive spirit and dedication, he has made impactful strides in antisense therapy.

Latest Patents

Among his latest inventions, Daniel Sejer Pedersen has developed a novel class of pharmaceuticals that incorporates Locked Nucleic Acid (LNA) for antisense therapy. These innovative oligonucleotides exhibit enhanced antisense properties and are composed of at least one LNA variant, specifically beta-D-thio/amino-LNA or alpha-L-oxy/thio/amino-LNA. Notably, his designs can integrate DNA and/or RNA nucleotides, pushing the boundaries of therapeutic possibilities.

Career Highlights

Daniel has worked with prominent organizations in the pharmaceutical sector, including Santaris Pharma A/S and Roche Innovation Center Copenhagen A/S. His experiences at these leading companies have enriched his expertise and provided him with a platform to advance his groundbreaking research in the field of pharmaceuticals.

Collaborations

Throughout his career, Daniel Sejer Pedersen has collaborated with several esteemed colleagues, including Troels Koch and Signe M. Christensen. These partnerships have fostered a dynamic collaborative environment, facilitating innovative ideas and reinforcing the importance of teamwork in scientific advancements.

Conclusion

In summary, Daniel Sejer Pedersen stands out as a notable inventor dedicated to revolutionizing antisense therapy through his work with Locked Nucleic Acids. His impressive patent portfolio and collaborations highlight his contributions to modern pharmaceuticals and underscore the vital role of innovation in healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…